| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
575 |
558 |
$406K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,341 |
1,292 |
$272K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,569 |
1,521 |
$134K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
118 |
117 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
116 |
115 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
160 |
151 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
173 |
158 |
$8K |
| 80050 |
General health panel |
133 |
131 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
128 |
125 |
$5K |
| 86803 |
|
94 |
92 |
$3K |
| 87070 |
|
106 |
95 |
$2K |
| 86780 |
|
90 |
88 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
55 |
55 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
90 |
87 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
26 |
25 |
$2K |
| 0012A |
|
30 |
29 |
$1K |
| 0011A |
|
27 |
27 |
$1K |
| 86704 |
|
39 |
39 |
$958.76 |
| 86705 |
|
39 |
39 |
$938.58 |
| 86706 |
|
39 |
39 |
$853.91 |
| 87340 |
|
38 |
38 |
$778.27 |
| 80061 |
Lipid panel |
15 |
15 |
$532.71 |
| 83655 |
|
12 |
12 |
$232.44 |
| 81001 |
|
15 |
15 |
$225.85 |
| 85027 |
|
12 |
12 |
$188.36 |
| 82248 |
|
12 |
12 |
$135.58 |